Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemia.

导出 LinkOut

翻译打印收藏纠错

作者： Junichi,Mukae ^[1] ; Daichi,Sadato ^[2] ; Takashi,Toya ^[3] ; Satoru,Watanabe ^[1] ; Chizuko,Hirama ^[4] ; Ryosuke,Konuma ^[2] ; Hiroaki,Shimizu ^[3] ; Yuho,Najima ^[1] ; Takeshi,Kobayashi ^[1] ; Motohiro,Kato ^[1] ; Kentaro,Ohki ^[1] ; Keisuke,Oboki ^[5] ; Hironori,Harada ^[4] ; Kazuteru,Ohashi ^[3] ; Takao,Deguchi ^[1] ; Yuka,Harada ^[6] ; Noriko,Doki ^[1]

作者单位： Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. ^[1] Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. ^[2] Research Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan. ^[3] Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan. ^[4] Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan. ^[5] School of Life Sciences, Laboratory of Oncology, Tokyo University of Pharmacy & Life Sciences, Tokyo, Japan. ^[6]

主题词人类(Humans);费城染色体(Philadelphia Chromosome);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);抗原, CD19(Antigens, CD19)

DOI 10.1080/10428194.2022.2116936

PMID 36102781

发布时间 2023-01-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交